Protagonist Therapeutics, Inc (PTGX) › Shareholders' EquityProtagonist Therapeutics, Inc (PTGX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2013: -$1.39M2014: -$12.62M2015: -$27.40M2016: $87.56M2017: $120.63M2018: $112.52M2019: $79.96M2020: $279.61M2021: $300.02M2022: $215.61M2023: $336.68M2024: $675.29M2025: $614.71M$614.71M2013Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$614.71M-9.0%2024$675.29M+100.6%2023$336.68M+56.2%2022$215.61M-28.1%2021$300.02M+7.3%2020$279.61M+249.7%2019$79.96M-28.9%2018$112.52M-6.7%2017$120.63M+37.8%2016$87.56M+419.5%2015-$27.40M-117.1%2014-$12.62M-805.4%2013-$1.39M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share